Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
European Organisation for Research and Treatment of Cancer - EORTC
Northside Hospital, Inc.
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center